Allianz Asset Management’s Axsome Therapeutics AXSM Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $658K | Buy |
6,300
+1,919
| +44% | +$200K | ﹤0.01% | 1332 |
|
2025
Q1 | $511K | Sell |
4,381
-1,114
| -20% | -$130K | ﹤0.01% | 1415 |
|
2024
Q4 | $465K | Buy |
+5,495
| New | +$465K | ﹤0.01% | 1435 |
|
2021
Q3 | – | Sell |
-10,760
| Closed | -$726K | – | 2023 |
|
2021
Q2 | $726K | Buy |
+10,760
| New | +$726K | ﹤0.01% | 1573 |
|
2021
Q1 | – | Sell |
-6,162
| Closed | -$502K | – | 1894 |
|
2020
Q4 | $502K | Sell |
6,162
-4,837
| -44% | -$394K | ﹤0.01% | 1611 |
|
2020
Q3 | $784K | Buy |
+10,999
| New | +$784K | ﹤0.01% | 1475 |
|
2020
Q2 | – | Sell |
-50,794
| Closed | -$2.99M | – | 1889 |
|
2020
Q1 | $2.99M | Buy |
50,794
+20,244
| +66% | +$1.19M | ﹤0.01% | 1145 |
|
2019
Q4 | $3.16M | Sell |
30,550
-641
| -2% | -$66.3K | ﹤0.01% | 1325 |
|
2019
Q3 | $631K | Sell |
31,191
-36,182
| -54% | -$732K | ﹤0.01% | 1824 |
|
2019
Q2 | $1.74M | Buy |
+67,373
| New | +$1.74M | ﹤0.01% | 1579 |
|
2018
Q1 | – | Sell |
-125,670
| Closed | -$704K | – | 2097 |
|
2017
Q4 | $704K | Hold |
125,670
| – | – | ﹤0.01% | 1818 |
|
2017
Q3 | $697K | Hold |
125,670
| – | – | ﹤0.01% | 1795 |
|
2017
Q2 | $723K | Sell |
125,670
-2,530
| -2% | -$14.6K | ﹤0.01% | 1782 |
|
2017
Q1 | $500K | Buy |
128,200
+18,110
| +16% | +$70.6K | ﹤0.01% | 1866 |
|
2016
Q4 | $743K | Hold |
110,090
| – | – | ﹤0.01% | 1762 |
|
2016
Q3 | $847K | Sell |
110,090
-9,150
| -8% | -$70.4K | ﹤0.01% | 1720 |
|
2016
Q2 | $899K | Hold |
119,240
| – | – | ﹤0.01% | 1666 |
|
2016
Q1 | $1.03M | Buy |
119,240
+2,075
| +2% | +$17.8K | ﹤0.01% | 1576 |
|
2015
Q4 | $1.08M | Buy |
+117,165
| New | +$1.08M | ﹤0.01% | 1538 |
|